Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial by Kim, Youn H, Prof, Bagot, Martine, Prof, Pinter-Brown, Lauren, MD, Rook, Alain H, MD, Porcu, Pierluigi, MD, Horwitz, Steven M, MD, Whittaker, Sean, Prof, Tokura, Yoshiki, MD, Vermeer, Maarten, MD, Zinzani, Pier Luigi, Prof, Sokol, Lubomir, MD, Morris, Stephen, MD, Kim, Ellen J, Prof, Ortiz-Romero, Pablo L, Prof, Eradat, Herbert, MD, Scarisbrick, Julia, MD, Tsianakas, Athanasios, MD, Elmets, Craig, MD, Dalle, Stephane, Prof, Fisher, David C, MD, Halwani, Ahmad, MD, Poligone, Brian, MD, Greer, John, Prof, Fierro, Maria Teresa, MD, Khot, Amit, MD, Moskowitz, Alison J, MD, Musiek, Amy, MD, Shustov, Andrei, MD, Pro, Barbara, Prof, Geskin, Larisa J, MD, Dwyer, Karen, BA, Moriya, Junji, MS, Leoni, Mollie, MD, Humphrey, Jeffrey S, MD, Hudgens, Stacie, MA, Grebennik, Dmitri O, MD, Tobinai, Kensei, MD, Duvic, Madeleine, Prof

Get full text

Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice by Moriya, Junji, MD, PhD, Wu, Xiumin, PhD, Zavala-Solorio, Jose, PhD, Ross, Jed, MS, Liang, Xiao Huan, MS, Ferrara, Napoleone, MD

Get full text